Vaxart Inc (VXRT)
NASDAQ:VXRT
Holding VXRT?
Track your performance easily

Vaxart (VXRT) Income Statement

4,092 Followers

Vaxart Income Statement

Last quarter (Q3 2023), Vaxart's total revenue was $446.00K, an increase of Infinity% from the same quarter last year. In Q3, Vaxart's net income was $-17.40M. See Vaxart’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 2.17M$ 107.00K$ 36.00K$ 4.05M$ 9.86M$ 4.16M
Cost of Revenue
------
Gross Profit
$ 3.46M$ 107.00K$ 36.00K---
Operating Expense
$ 44.01M$ 114.69M$ 72.12M$ 35.06M$ 20.73M$ 23.96M
Operating Income
$ -40.72M$ -114.59M$ -72.12M$ -31.02M$ -10.87M$ -19.80M
Net Non Operating Interest Income Expense
$ 2.67M$ 1.25M$ 81.00K$ -1.80M$ -2.24M$ -2.62M
Other Income Expense
$ 3.61M$ 4.25M$ 2.11M$ 836.00K$ -5.05M$ 4.52M
Pretax Income
$ -88.91M$ -107.69M$ -74.15M$ -31.98M$ -18.16M$ -17.90M
Tax Provision
$ 45.00K$ 67.00K$ 107.00K$ 238.00K$ 490.00K$ 109.00K
Earnings From Equity Interest Net Of Tax
--$ 0.00---
Net Income Common Stockholders
$ -36.46M$ -107.76M$ -74.26M$ -32.22M$ -18.64M$ -18.35M
Basic EPS
$ -0.64$ -0.84$ -0.58$ -0.36$ -0.86$ -2.90
Diluted EPS
$ -0.46$ -0.84$ 0.00$ -0.36$ -0.86$ -2.90
Basic Average Shares
$ 554.52M$ 127.68M$ 121.45M$ 88.30M$ 21.57M$ 6.32M
Diluted Average Shares
$ 426.83M$ 127.68M$ 0.00$ 88.30M$ 21.57M$ 6.32M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 44.01M$ 114.69M$ 72.12M$ 35.06M$ 20.73M$ 23.96M
Net Income From Continuing And Discontinued Operation
$ -89.01M$ -107.76M$ -74.26M$ -32.22M$ -18.64M$ -18.01M
Normalized Income
---$ -32.83M$ -14.96M$ -21.31M
Interest Expense
---$ 1.87M$ 2.39M$ 2.68M
EBIT
$ -89.94M$ -113.35M$ -74.23M$ -30.11M$ -15.77M$ -15.22M
EBITDA
$ -81.75M$ -107.54M$ -70.03M$ -27.40M$ -12.17M$ -12.02M
Currency in USD

Vaxart Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis